Mid-Cap Companies Medical Devices and Equipment Listed on U.S. Exchanges
A comprehensive directory of mid-cap medical device and equipment stocks with market capitalizations between $2 billion and $10 billion, featuring 2026 performance data, clinical pipeline highlights, and sector analysis.
This list includes mid-sized medical device, instrument, equipment, and supply companies. We focus on firms with market capitalizations between two billion and ten billion dollars. These companies medical devices represent the backbone of healthcare innovation and specialized patient care.
We update this page at the start of every month to reflect market changes. It is possible for a company's market cap to fluctuate outside the mid-cap range during the month. The mid-cap medical device sector in 2026 is currently experiencing strong momentum.
Growth is driven by neurovascular innovations, diabetes technology adoption, and AI-enabled diagnostics. Notable leaders include Penumbra (PEN), DexCom (DXCM), and Repligen (RGEN). Additional medtech stocks can be found in the sections linked below.
Key Takeaways for Investors
Mid-cap companies are at the forefront of innovation in neurovascular treatment and minimally invasive surgery. Explore all medical device stocks across market caps for broader sector context.
Leading mid-cap stocks have outperformed in 2026, with Penumbra (PEN) up approximately 23% YTD. DexCom (DXCM) continues to benefit from expanding continuous glucose monitor adoption and favorable reimbursement trends.
Mid-cap device companies are frequent acquisition targets for larger strategics seeking innovative technologies. Recent deals in diagnostics and organ preservation highlight continued consolidation in the $500B+ global medical device market.
Use the Mid-Cap Medical Device Industry Comparison Widget to analyze trends and earnings. This tool helps investors review P/E ratios and beta across the entire sector list.
Valuation Catalysts for Mid-Cap Medtech
Understanding the valuation of companies medical devices requires a focus on R&D efficiency and FDA clearance timelines. Mid-cap firms often trade at a premium compared to large-cap peers due to their higher growth potential and agility.
Key metrics for this sector include the Enterprise Value to EBITDA (EV/EBITDA) ratio and R&D spending as a percentage of total sales. High R&D reinvestment often signals a robust pipeline of future surgical or diagnostic tools.
Market adoption rates for new technologies, such as robotic-assisted surgery or remote patient monitoring, are also critical. Investors should monitor how these mid-cap players capture market share from established industry giants.
Top Mid-Cap Companies Medical Devices by Market Cap (2026)
The following table provides a comparative overview of leading companies medical devices. These entities are listed on major U.S. exchanges and represent diverse therapeutic areas.
| Rank | Ticker | Company | Industry | Market Cap | YTD % | P/E Ratio | Div Yield |
|---|---|---|---|---|---|---|---|
| 1 | RMD | ResMed Inc. | Respiratory | $12.5B | +8.2% | 28.5 | 0.9% |
| 2 | COO | Cooper Companies | Eyes | $11.8B | +6.4% | 25.3 | N/A |
| 3 | WST | West Pharmaceutical Services | Drug Delivery | $10.5B | +11.3% | 35.2 | 0.3% |
| 4 | STE | Steris Corporation | Medical Devices | $9.8B | +5.7% | 32.8 | 0.8% |
| 5 | BIO | Bio-Rad Laboratories | Medical Devices | $9.2B | -2.1% | 28.9 | N/A |
| 6 | ALGN | Align Technology | Dental | $8.9B | +14.5% | 38.4 | N/A |
| 7 | DXCM | DexCom Inc. | Diabetes | $8.7B | +16.2% | 42.1 | N/A |
| 8 | TFX | Teleflex Incorporated | Medical Devices | $8.2B | +4.8% | 26.7 | 0.6% |
| 9 | BRKR | Bruker Corporation | Medical Devices | $7.5B | +9.2% | 30.5 | 0.2% |
| 10 | HAE | Haemonetics Corporation | Blood | $6.8B | +7.5% | 24.8 | N/A |
Strategic Importance of Mid-Cap Device Manufacturers
Mid-cap manufacturers occupy a unique sweet spot in the healthcare ecosystem. They possess the scale to manage global supply chains while remaining focused on specialized medical niches.
Many of these companies medical devices are leaders in high-barrier categories like cardiac rhythm management or spinal implants. Their specialized focus often makes them "pure-play" investments that are easier to analyze than diversified conglomerates.
Furthermore, these companies frequently drive the development of "value-based" healthcare solutions. By reducing surgical recovery times or improving diagnostic accuracy, they provide significant clinical and financial value to hospital systems.
Mid-Cap Companies Medical Devices — Complete Company List
Additional medical device companies can be found in the following sections:
List of Medical Device Companies Large-Cap Medical Device Companies Small-Cap Medical Device Companies Micro-Cap Medical Device Companies Nano-Cap Medical Device CompaniesThe list below categorizes companies medical devices by their primary area of therapeutic focus. A comparison widget showing trends and EPS can be accessed through the link below.
Mid-Cap Medical Device Industry Comparison WidgetSelect a company link to access charts, news, and official website information.
Medical Devices: Mid-Cap Stocks
- Bio-Rad Laboratories, Inc. (BIO) (Life Science: laboratory instruments, consumables, and reagents for medical screening and diagnostics)
- Bruker Corporation (BRKR) (Analytical instruments including atomic force microscopy, spectroscopy, and X-ray technologies)
- Hill-Rom Holdings Inc. (HRC) (Hospital furniture, beds, stretchers, support surfaces, and surgical products)
- ICU Medical, Inc. (ICUI) (Devices used in critical care, oncology, and vascular therapy)
- PerkinElmer, Inc. (PKI) (Neonatal screening, cancer treatment software, and environmental testing)
- Steris Corporation (STE) (Infection prevention and surgical products including sterilizers and surgical tables)
- Teleflex Incorporated (TFX) (Single-use devices for anesthesia, cardiac care, urology, and vascular access)
- Varian Medical Systems, Inc. (VAR) (Oncology treatment systems and X-ray imaging products)
Blood and Dental
- Haemonetics Corporation (HAE) (Blood management devices, services, and software)
- Align Technology, Inc. (ALGN) (Digital dental equipment and orthodontic aligners)
Diabetes and Drug Delivery
- DexCom, Inc. (DXCM) (Continuous glucose monitoring systems)
- Insulet Corporation (PODD) (Tubeless insulin pumps and diabetes supply distribution)
- West Pharmaceutical Services, Inc. (WST) (Drug delivery systems and pre-fillable packaging solutions)
Specialized Care: Eyes, Heart, and Kidney
- Cooper Companies, Inc. (The) (COO) (Soft contact lenses and women's healthcare devices)
- Abiomed Inc. (ABMD) (Heart support pumps and artificial heart technology)
- LivaNova plc (LIVN) (Cardiac rhythm management and neuromodulation technology)
- Cantel Medical Corp. (CMD) (Water purification and endoscopy reprocessing systems)
Monitoring and Orthopedics
- Masimo Corporation (MASI) (Non-invasive patient monitoring technologies)
- Integra LifeSciences Holdings Corporation (IART) (Regenerative technology implants and surgical instruments)
- Wright Medical Group N.V. (WMGI) (Devices for upper and lower extremity orthopedic markets)
Respiratory, Spine, and Strokes
- ResMed Inc. (RMD) (Sleep apnea and respiratory medicine equipment)
- Globus Medical, Inc. (GMED) (Musculoskeletal implants and robotic navigation)
- Penumbra, Inc. (PFN) (Medical devices for strokes and neurovascular conditions)
Risks & Considerations
Regulatory and Reimbursement Risk
Companies medical devices face stringent FDA approval processes. Delays in product approvals or unfavorable reimbursement changes from insurers can materially impact revenue projections for mid-cap makers.
Clinical Trial and Liability
New device technologies require extensive clinical validation. Trial failures or safety concerns can trigger significant stock price declines and expose companies to litigation risk.
Technological Obsolescence
The medtech industry is characterized by rapid innovation. Mid-cap companies must continuously invest in R&D to maintain positioning against larger incumbents and disruptive startups.
Hospital Spending Cycles
Many device companies rely on hospital capital equipment purchases. Deferred spending during periods of economic pressure can create revenue lumpiness and earnings volatility.